Literature DB >> 22700435

Mitochondrial dysfunction in neurodegenerative diseases.

Ashu Johri1, M Flint Beal.   

Abstract

Neurodegenerative diseases are a large group of disabling disorders of the nervous system, characterized by the relative selective death of neuronal subtypes. In most cases, there is overwhelming evidence of impaired mitochondrial function as a causative factor in these diseases. More recently, evidence has emerged for impaired mitochondrial dynamics (shape, size, fission-fusion, distribution, movement etc.) in neurodegenerative diseases such as Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. Here, we provide a concise overview of the major findings in recent years highlighting the importance of healthy mitochondria for a healthy neuron.

Entities:  

Mesh:

Year:  2012        PMID: 22700435      PMCID: PMC3422529          DOI: 10.1124/jpet.112.192138

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  98 in total

1.  High frequency of mitochondrial complex I mutations in Parkinson's disease and aging.

Authors:  Rafal Smigrodzki; Janice Parks; W Davis Parker
Journal:  Neurobiol Aging       Date:  2004 Nov-Dec       Impact factor: 4.673

2.  Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.

Authors:  Julie A Harris; Nino Devidze; Laure Verret; Kaitlyn Ho; Brian Halabisky; Myo T Thwin; Daniel Kim; Patricia Hamto; Iris Lo; Gui-Qiu Yu; Jorge J Palop; Eliezer Masliah; Lennart Mucke
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

Review 3.  Nuclear receptors as therapeutic targets for Alzheimer's disease.

Authors:  Shweta Mandrekar-Colucci; Gary E Landreth
Journal:  Expert Opin Ther Targets       Date:  2011-07-01       Impact factor: 6.902

4.  Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

Authors:  Julie St-Pierre; Stavit Drori; Marc Uldry; Jessica M Silvaggi; James Rhee; Sibylle Jäger; Christoph Handschin; Kangni Zheng; Jiandie Lin; Wenli Yang; David K Simon; Robert Bachoo; Bruce M Spiegelman
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

5.  Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

Authors:  Patrick Weydt; Victor V Pineda; Anne E Torrence; Randell T Libby; Terrence F Satterfield; Eduardo R Lazarowski; Merle L Gilbert; Gregory J Morton; Theodor K Bammler; Andrew D Strand; Libin Cui; Richard P Beyer; Courtney N Easley; Annette C Smith; Dimitri Krainc; Serge Luquet; Ian R Sweet; Michael W Schwartz; Albert R La Spada
Journal:  Cell Metab       Date:  2006-10-19       Impact factor: 27.287

Review 6.  Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.

Authors:  P Hemachandra Reddy; Tejaswini P Reddy; Maria Manczak; Marcus J Calkins; Ulziibat Shirendeb; Peizhong Mao
Journal:  Brain Res Rev       Date:  2010-12-08

7.  MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease.

Authors:  D Galter; K Pernold; T Yoshitake; E Lindqvist; B Hoffer; J Kehr; N-G Larsson; L Olson
Journal:  Genes Brain Behav       Date:  2009-10-07       Impact factor: 3.449

8.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

Authors:  Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph D Buxbaum; Giulio M Pasinetti
Journal:  Arch Neurol       Date:  2009-03

9.  Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli.

Authors:  Veronica Costa; Marta Giacomello; Roman Hudec; Raffaele Lopreiato; Gennady Ermak; Dmitri Lim; Walter Malorni; Kelvin J A Davies; Ernesto Carafoli; Luca Scorrano
Journal:  EMBO Mol Med       Date:  2010-12       Impact factor: 12.137

10.  Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.

Authors:  Wenjun Song; Jin Chen; Alejandra Petrilli; Geraldine Liot; Eva Klinglmayr; Yue Zhou; Patrick Poquiz; Jonathan Tjong; Mahmoud A Pouladi; Michael R Hayden; Eliezer Masliah; Mark Ellisman; Isabelle Rouiller; Robert Schwarzenbacher; Blaise Bossy; Guy Perkins; Ella Bossy-Wetzel
Journal:  Nat Med       Date:  2011-02-20       Impact factor: 53.440

View more
  221 in total

Review 1.  Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.

Authors:  Mohammed Akbar; Musthafa Mohamed Essa; Ghazi Daradkeh; Mohamed A Abdelmegeed; Youngshim Choi; Lubna Mahmood; Byoung-Joon Song
Journal:  Brain Res       Date:  2016-02-13       Impact factor: 3.252

Review 2.  Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.

Authors:  Shyamal Desai; Meredith Juncker; Catherine Kim
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-09

3.  Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease.

Authors:  Juan I Sbodio; Bindu D Paul; Carolyn E Machamer; Solomon H Snyder
Journal:  Cell Rep       Date:  2013-09-05       Impact factor: 9.423

4.  An Exome-Wide Association Study Identifies New Susceptibility Loci for Age of Smoking Initiation in African- and European-American Populations.

Authors:  Keran Jiang; Zhongli Yang; Wenyan Cui; Kunkai Su; Jennie Z Ma; Thomas J Payne; Ming D Li
Journal:  Nicotine Tob Res       Date:  2019-05-21       Impact factor: 4.244

Review 5.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

6.  MISTERMINATE Mechanistically Links Mitochondrial Dysfunction with Proteostasis Failure.

Authors:  Zhihao Wu; Ishaq Tantray; Junghyun Lim; Songjie Chen; Yu Li; Zoe Davis; Cole Sitron; Jason Dong; Suzana Gispert; Georg Auburger; Onn Brandman; Xiaolin Bi; Michael Snyder; Bingwei Lu
Journal:  Mol Cell       Date:  2019-08-01       Impact factor: 17.970

7.  Dynamin-Related Protein 1 Promotes Mitochondrial Fission and Contributes to The Hippocampal Neuronal Cell Death Following Experimental Status Epilepticus.

Authors:  Shang-Der Chen; Yen-Yi Zhen; Jui-Wei Lin; Tsu-Kung Lin; Chin-Wei Huang; Chia-Wei Liou; Samuel H H Chan; Yao-Chung Chuang
Journal:  CNS Neurosci Ther       Date:  2016-08-31       Impact factor: 5.243

8.  Phosphatidylethanolamine deficiency in Mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology.

Authors:  Guergana Tasseva; Helin Daniel Bai; Magdalena Davidescu; Alois Haromy; Evangelos Michelakis; Jean E Vance
Journal:  J Biol Chem       Date:  2012-12-18       Impact factor: 5.157

9.  Mitochondrial Protection and Anti-inflammatory Effects Induced by Emodin in the Human Neuroblastoma SH-SY5Y Cells Exposed to Hydrogen Peroxide: Involvement of the AMPK/Nrf2 Signaling Pathway.

Authors:  Marcos Roberto de Oliveira; Izabel Cristina Custódio de Souza; Flávia Bittencourt Brasil
Journal:  Neurochem Res       Date:  2020-11-21       Impact factor: 3.996

10.  An Automated Multidose Synthesis of the Potentiometric PET Probe 4-[18F]Fluorobenzyl-Triphenylphosphonium ([18F]FBnTP).

Authors:  Christopher M Waldmann; Adrian Gomez; Phillip Marchis; Sean T Bailey; Milica Momcilovic; Anthony E Jones; David B Shackelford; Saman Sadeghi
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.